C F Bryan

Summary

Affiliation: Midwest Transplant Network
Country: USA

Publications

  1. ncbi Blood group A isoagglutinins in A(2) → O simultaneous liver/kidney transplantation may not influence kidney function
    C F Bryan
    Midwest Transplant Network Laboratory, Westwood, KS, USA
    Am J Transplant 11:1527-30. 2011
  2. ncbi Long-term survival of kidneys transplanted from live A2 donors to O and B recipients
    C F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Am J Transplant 7:1181-4. 2007
  3. ncbi Renal graft survival is not influenced by a positive flow B-cell crossmatch
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205 1867, USA
    Clin Transplant 21:72-9. 2007
  4. ncbi Implications of ABO error rates in proficiency testing for solid organ transplantation
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Transplantation 82:733-6. 2006
  5. ncbi Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205 1867, USA
    Clin Transplant 20:563-70. 2006
  6. ncbi Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205, USA
    Transplantation 80:75-80. 2005
  7. ncbi ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Clin Transplant 18:55-60. 2004
  8. ncbi The risk for Chagas' disease in the Midwestern United States organ donor population is low
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66025 1867, USA
    Clin Transplant 18:12-5. 2004
  9. ncbi IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype
    C F Bryan
    Midwest Transplant Network, Westwood, Kansas 66205, USA
    Clin Transplant 15:28-35. 2001
  10. ncbi Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft
    C F Bryan
    Midwest Transplant Network, Inc, Westwood, Kansas 66205, USA
    Transplantation 71:875-9. 2001

Collaborators

Detail Information

Publications16

  1. ncbi Blood group A isoagglutinins in A(2) → O simultaneous liver/kidney transplantation may not influence kidney function
    C F Bryan
    Midwest Transplant Network Laboratory, Westwood, KS, USA
    Am J Transplant 11:1527-30. 2011
    ....
  2. ncbi Long-term survival of kidneys transplanted from live A2 donors to O and B recipients
    C F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Am J Transplant 7:1181-4. 2007
    ..These data show that good long-term graft survival can be expected in live-donor A(2) to O and B transplantation despite some of those patients experiencing the type of clinical problems seen with ABO-compatible transplants...
  3. ncbi Renal graft survival is not influenced by a positive flow B-cell crossmatch
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205 1867, USA
    Clin Transplant 21:72-9. 2007
    ..The influence of a positive B-cell crossmatch on graft outcome in renal transplantation is controversial...
  4. ncbi Implications of ABO error rates in proficiency testing for solid organ transplantation
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Transplantation 82:733-6. 2006
  5. ncbi Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205 1867, USA
    Clin Transplant 20:563-70. 2006
    ....
  6. ncbi Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205, USA
    Transplantation 80:75-80. 2005
    ..However, this practice is controversial, and long-term data are lacking. This study analyzed the long-term outcomes of A2/A2B deceased donor kidneys transplanted into selected B recipients...
  7. ncbi ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Clin Transplant 18:55-60. 2004
    ..The national HLA-0 mm kidney allocation sharing system's imbalance by ABO blood group could be partially resolved in the future by allocating HLA-0 mm blood group A(2) kidneys to B patients...
  8. ncbi The risk for Chagas' disease in the Midwestern United States organ donor population is low
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66025 1867, USA
    Clin Transplant 18:12-5. 2004
    ....
  9. ncbi IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype
    C F Bryan
    Midwest Transplant Network, Westwood, Kansas 66205, USA
    Clin Transplant 15:28-35. 2001
    ..They also suggest that the strength of the IgM antibody response is regulated in part by certain gene (s) of the DR region...
  10. ncbi Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft
    C F Bryan
    Midwest Transplant Network, Inc, Westwood, Kansas 66205, USA
    Transplantation 71:875-9. 2001
    ..9%+/-33.9; n=24) compared with the CIT > or = 15 hr group (46.3%+/-36.5; n=66) (P<0.001). CONCLUSION: Longer CIT induces a humorally more immunogenic kidney...
  11. ncbi The influence of age, gender and ethnicity on cadaveric organ recovery rate
    P W Nelson
    Midwest Transplant Network, Westwood, KS 66205, USA
    Clin Transplant 15:6-10. 2001
    ..Increasing organ recovery and transplantation of organs from donors from the two age extremes results in less gain in the number of organs/million population than recovery from the 11-50 age range...
  12. ncbi Point-of-care testing in an organ procurement organization donor management setting
    K A Baier
    Midwest Transplant Network, Westwood, KS 66205, USA
    Clin Transplant 17:48-51. 2003
    ..Our organ procurement organization (OPO) evaluated the clinical and financial efficacy of point-of-care testing (POCT) in management of our deceased organ donors...
  13. ncbi Cold ischaemia time added to kidneys can be minimized by completing the final cross-match before organs are taken from the operating room
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205, USA
    Clin Transplant 17:58-64. 2003
    ..Our organ procurement organization (OPO) and HLA laboratories have taken the approach of performing the histocompatibility testing, including the final cross-match, as early in the donor process as possible...
  14. ncbi HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS, USA
    Am J Transplant 3:459-64. 2003
    ....
  15. ncbi Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates
    Christopher F Bryan
    Midwest Transplant Network, Westwood, KS 66205, USA
    Clin Transplant 16:15-23. 2002
    ..These data provided our histocompatibility laboratory with the rationale to stop performing the AHG PRA and perform only the flow Class I PRA method for regraft candidates...
  16. ncbi Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?
    Paul W Nelson
    Saint Luke s Hospital and the University of Missouri, Kansas City, USA
    Am J Transplant 2:94-9. 2002
    ..55). These data support the national trial for additional OPOs to voluntarily allocate A2 and A2B kidneys preferentially to B waiting list candidates, thus increasing access of blood group B patients to renal transplantation...